Skip to main content

Dienogest use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Jul 24, 2022.

Drugs containing Dienogest: Natazia

Dienogest Levels and Effects while Breastfeeding

Summary of Use during Lactation

Dienogest is only available in the United States in a combination oral contraceptive product that also contains estradiol valerate. Based on the available evidence, expert opinion holds that nonhormonal methods are preferred during breastfeeding and progestin-only contraceptives are preferred over combined oral contraceptives in breastfeeding women, especially during the first 4 weeks postpartum. For further information, consult the record entitled, Contraceptives, Oral, Combined.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Dienogest

CAS Registry Number

65928-58-7

Drug Class

Breast Feeding

Lactation

Contraceptive Agents, Female

Contraceptives, Oral, Synthetic

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.